BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons with Tetraplegia

“Turn thoughts into action” for people living with paralysis

a study on Tetraplegia Spinal Cord Injury Amyotropic Lateral Sclerosis (ALS) Brain Stem Infarctions Locked in Syndrome Muscular Dystrophy

Summary

Eligibility
for people ages 18-80 (full criteria)
Location
at UC Davis
Dates
study started
completion around

Description

Summary

The purpose of this study is to obtain preliminary device safety information and demonstrate proof of principle (feasibility) of the ability of people with tetraplegia to control a computer cursor and other assistive devices with their thoughts.

Details

The goal of the BrainGate2 research and development project is to identify the core methods and features for a medical device that could allow people with paralysis, including severe speech impairment, to recover a host of abilities that normally rely on the hands or on speech.

Keywords

Tetraplegia, Spinal Cord Injuries, Amyotrophic Lateral Sclerosis, Brain Stem Infarctions, Locked in Syndrome, Muscular Dystrophy, Brain computer interface, Assistive device, Environmental control, Communication device, quadriplegia, Muscular Dystrophies, Motor Neuron Disease, Locked-In Syndrome, Placement of the BrainGate2 sensor(s) into the motor-related cortex, BrainGate

Eligibility

You can join if…

Open to people ages 18-80

You CAN'T join if...

  • Visual impairment such that extended viewing of a computer monitor would be difficult even with ordinary corrective lenses
  • Chronic oral or intravenous steroids or immunosuppressive therapy
  • Other serious disease or disorder that could seriously affect ability to participate in the study
  • (There are additional exclusion criteria)

Locations

  • University of California, Davis accepting new patients
    Sacramento California 95817 United States
  • Stanford University School of Medicine accepting new patients
    Stanford California 94305 United States

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Leigh R. Hochberg, MD, PhD.
Links
Home Page for BrainGate Research
ID
NCT00912041
Study Type
Interventional
Participants
Expecting 27 study participants
Last Updated